Plerixafor Added to Chemotherapy Plus G-CSF Is Safe and Allows Adequate PBSC Collection in Predicted Poor Mobilizer Patients With Multiple Myeloma or Lymphoma

Biology of Blood and Marrow Transplantation - Netherlands
doi 10.1016/j.bbmt.2011.07.014
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Intermediate-Dose Ara-C Plus G-CSF for Stem Cell Mobilization in Patients With Lymphoid Malignancies, Including Predicted Poor Mobilizers

Bone Marrow Transplantation
TransplantationHematology
2013English

Comparison of Peripheral Blood Progenitor Cell Mobilization in Patients With Multiple Myeloma: High-Dose Cyclophosphamide Plus GM-CSF vs G-CSF Alone

Bone Marrow Transplantation
TransplantationHematology
1997English

Development and Implementation of Plerixafor Plus G-CSF Mobilization Algorithm for Autologous Stem Cell Transplant (ASCT) in Multiple Myeloma (MM) Patients Treated at Memorial Sloan-Kettering Cancer Center (MSKCC)

Biology of Blood and Marrow Transplantation
TransplantationHematology
2012English

Increased Efficacy of Stem Cell Chemo-Mobilization With Intermediate-Dose Cytarabine Plus G-CSF Compared With G-CSF Alone in Patients With Multiple Myeloma: Results of a Randomized Trial,

Biology of Blood and Marrow Transplantation
TransplantationHematology
2019English

Myeloablative Timed Sequential Busulfan Is Safe in Patients With Relapsed or High-Risk Multiple Myeloma

Biology of Blood and Marrow Transplantation
TransplantationHematology
2016English

Differences in Cellular Composition of Peripheral Blood Stem Cell Grafts From Healthy Stem Cell Donors Mobilized With Either G-CSF Alone or G-CSF and Plerixafor

Biology of Blood and Marrow Transplantation
TransplantationHematology
2018English

Infectious Complications After High-Dose Chemotherapy and Autologous Stem Cell Transplantation: Comparison Between Patients With Lymphoma or Multiple Myeloma and Patients With Solid Tumors

Bone Marrow Transplantation
TransplantationHematology
2001English

Impact of Plerixafor Use at Different Peripheral Blood CD34+ Cell Thresholds on Autologous Stem Cell Collection in Patients With Multiple Myeloma

Biology of Blood and Marrow Transplantation
TransplantationHematology
2018English

rhTPO Combined With Chemotherapy and G-CSF for Autologous Peripheral Blood Stem Cells in Patients With Refractory/Relapsed Non-Hodgkin’s Lymphoma

Cancer Management and Research
Oncology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy